Run Antimicrobial Stewardship Audit — Free

Audit Context

Patient or case identifier recorded

Record the chart number, encounter ID, or audit case reference used for this review.

Antimicrobial regimen reviewed

Document the antimicrobial agent(s), dose, route, and frequency being audited.

Review date and reviewer documented

Enter the date/time of the stewardship review and the reviewer name or role.

Note (optional)

Review type identified

Select the audit context for this review.

Note (optional)

Clinical Indication

Documented indication present critical (required)

A specific infection or prophylaxis indication is documented in the chart or order.

Yes No N/A

Indication is clinically appropriate critical (required)

The documented indication is supported by signs, symptoms, labs, imaging, or procedural context.

Yes No N/A

Therapy is treatment rather than unnecessary prophylaxis

Confirm the antimicrobial is justified as treatment, targeted prophylaxis, or guideline-supported prophylaxis.

Yes No N/A

Source of infection identified when applicable

If relevant, the suspected or confirmed source is documented (for example: urinary, respiratory, skin/soft tissue, intra-abdominal, bloodstream).

Yes No N/A

Agent Selection and Regimen

Agent selection aligns with likely or confirmed pathogen critical (required)

The chosen antimicrobial is appropriate for the suspected organism(s), infection site, and local guidance.

Yes No N/A

Spectrum is as narrow as clinically appropriate

Broad-spectrum therapy is avoided when a narrower agent would provide adequate coverage.

Yes No N/A

Dose, route, and frequency are appropriate critical (required)

The regimen matches patient factors such as renal/hepatic function, weight, severity of illness, and site of infection.

Yes No N/A

Allergy or intolerance considerations addressed

Documented allergies, prior adverse reactions, and intolerance history were considered in agent selection.

Yes No N/A

Therapeutic duplication absent

No unnecessary duplicate antimicrobial coverage is present unless specifically justified.

Yes No N/A

Duration and Stop Date

Planned duration or stop date documented critical (required)

A clear stop date, planned duration, or review date is documented in the order or progress note.

Yes No N/A

Duration is consistent with guideline or indication critical (required)

The planned duration is consistent with the infection type, source control status, and clinical response.

Yes No N/A

IV-to-PO conversion considered when clinically appropriate

Oral step-down was considered when the patient was hemodynamically stable, improving, and able to absorb oral therapy.

Yes No N/A

Therapy reassessment documented within expected timeframe

The regimen was reassessed at an appropriate interval for ongoing need and duration adjustment.

Yes No N/A

De-escalation and Culture Review

Cultures obtained before antibiotics when clinically indicated critical (required)

Appropriate cultures or diagnostic specimens were collected before antimicrobial initiation when feasible and indicated.

Yes No N/A

Culture and susceptibility results reviewed critical (required)

Available microbiology results were reviewed and documented in the stewardship assessment.

Yes No N/A

Therapy de-escalated when results supported narrowing

Broad therapy was narrowed, stopped, or adjusted based on culture, susceptibility, or clinical data when appropriate.

Yes No N/A

Negative or contaminant cultures prompted reassessment

If cultures were negative or suggested contamination, the need for continued therapy was reassessed and documented.

Yes No N/A

Documentation and Stewardship Notes

Stewardship recommendation documented

Document any recommendation to continue, stop, narrow, switch to oral therapy, or obtain additional diagnostics.

Recommendation communicated to care team

Confirm the recommendation was communicated to the responsible clinician, pharmacist, or team.

Yes No N/A

Follow-up plan documented

Record any required follow-up, such as repeat review date, lab monitoring, or culture follow-up.

Get your results

Enter your email — we'll send you a PDF of your filled-out template, plus the occasional MangoScoop newsletter (templates, workflow tips, product updates). Unsubscribe anytime — link is in every email.

Email (required)

Your name (optional)

Run: Antimicrobial Stewardship Audit

Audit Context

Clinical Indication

Agent Selection and Regimen

Duration and Stop Date

De-escalation and Culture Review

Documentation and Stewardship Notes

Get your results